Aim-To compare the techniques and results of a nested PCR and an immunofluorescence assay (IFA) for the detection of Pneumocystis carinii infection; to consider the role of the nested PCR in the diagnosis of P carinii pneumonia (PCP). Methods-Serial dilutions of two known P carinii positive samples were tested by IFA and PCR to determine their relative sensitivities. Seventy eight respiratory samples (15 from 11 patients with HIV infection/ acquired immunodeficiency syndrome (AIDS) and 63 from 42 patients with other forms of immunodeficiency) were tested using both assays, and the costs and technical requirements of each assay were assessed. Various DNA amplification methods have been published which detect P carinii, but the nested PCR has a number of distinct advantages over those which require probing of the DNA product by Southern blot hybridisation. The assay time is shorter, less technical training is required and the cost of the test is lower.3 Nevertheless, some pathologists consider that the PCR is an expensive and technically complicated assay when compared with the IFA currently in routine use and thus PCR is reserved only for specialised laboratories. This paper attempts to identify the role of the PCR in the diagnosis of PCP.
to consider the role of the nested PCR in the diagnosis of P carinii pneumonia (PCP) . Methods-Serial dilutions of two known P carinii positive samples were tested by IFA and PCR to determine their relative sensitivities. Seventy eight respiratory samples (15 from 11 patients with HIV infection/ acquired immunodeficiency syndrome (AIDS) and 63 from 42 patients with other forms of immunodeficiency) were tested using both assays, and the costs and technical requirements of each assay were assessed. Results-The PCR had a greater relative sensitivity over the IFA of 2 x 101 to 2 x 103 fold in a postmortem lung sample and 2 x 105 to 2 x 106 fold in a bronchoalveolar lavage sample from a patient with PCP. P carinii was detected in all 15 samples from the patients with HIV/AIDS by both IFA and PCR. Of the 63 samples from the patients with immunodeficiencies other than HIV/AIDS, the PCR was more sensitive than IFA. Conclusions-The nested PCR is a more sensitive assay than the IFA. It may be useful in the diagnosis of PCP in patients with immunodeficiencies other than HIV/ AIDS. Similarly, PCR may be of benefit for this patient group as less invasive specimens are needed. PCR has an increasing role to play in the diagnosis of PCP in the routine laboratory. The relative costs of PCR and the IFA were assessed in terms of labour, accommodation, consumables, and capital equipment. The overall assay time for PCR (eight hours) is longer but the operator time is shorter (two hours) than for the IFA (three to four hours). PCR time is also more predictable, with less frequent Diagnosis of P carinii pneumonia using PCR requirement for repeat testing and a lower fractional time increment per additional test sample. The overall skill requirements for the tests are similar; PCR demands more stringent precautions against cross contamination but these can be met by the judicious use of existing accommodation. The cost per separate PCR assay for consumables, including Taq polymerase, buffer, primers, dNTPs, DNA marker ladder, photographic film, and plastics is approximately £1 5, which doubles when 10 samples are tested simultaneously. This compares with about £20 per IFA test regardless of whether the 10 assays in the kit are used separately or simultaneously. PCR capital costs are also lower, £4500-5000 (before VAT) for thermal cycler, transilluminator and electrophoresis apparatus compared with £1 0000-12 000 for a fluorescence microscope.
Discussion
The results of dilution experiments confirm that the PCR is more sensitive than the IFA for the detection of P carinii organisms in respiratory samples. The 2 x 10' to 2 x 103 increase in the sensitivity of the PCR with the postmortem lung sample is likely to be because of the inherent sensitivity of the technique and its ability to detect individual organisms; a single cyst can contain up to eight organisms. The relative sensitivity of the PCR with the BAL sample was greater by 2 x 105 to 2 x 106 fold. The increase in sensitivity may also be because of the detection of the trophozoite form of the organism which is considered to be at least 100 times more numerous than cysts in a BAL sample.6 The cyst density (and perhaps the trophozoite population) in BAL and induced sputum samples can vary in HIV/ AIDS patients with PCP and there is also a correlation between patient survival and the predominant stage ofthe organism.' Therefore, because PCR can be used to detect both the cyst and trophozoite forms of P carinii, it may be of more use in the diagnostic laboratory.
The patients with HIV/AIDS were analysed separately from those with other immunodeficiencies as they tend to have had symptoms longer8 and have a greater organism load in their BAL and induced sputum samples than patients with other immunodeficiencies.9 In the patients with HIV/AIDS the IFA was as sensitive as PCR, whereas in those with other immunodeficiencies PCR was significantly more sensitive than the IFA (p<0 001). At present, as invasive procedures are required for specimen collection, most clinicians avoid taking sequential specimens if possible, unless there is difficulty in making a diagnosis. In the present study sequential specimens from around the time of infection were available from 10 of 53 patients. In seven the results on PCR and IFA were in agreement, but in the remaining three the PCR results were positive and the IFA negative. In one patient an initial induced sputum sample was positive on PCR only, but a second sample taken a day later was also positive on IFA. In another patient (patient 2, table 3) a BAL sample was PCR positive followed by a tracheal sample a day later; however, the IFA was negative in both samples. In both of these patients PCR therefore enabled a diagnosis to be made and treatment to be instigated earlier. Specimens from a third patient (patient 4, table 3) demonstrate how the IFA becomes negative earlier after treatment than PCR. PCR may still be useful in such a situation when retrospective confirmation of diagnosis is required in patients already receiving treatment.
Apart from equalling or improving upon the sensitivity and specificity of the IFA, PCR, to become a routine test, should also fulfil the following additional criteria: a short procedure time, within one working day or less, technical ease and the cost should not be prohibitive. Although the IFA has the advantage of being a shorter assay than the PCR when >5 cysts/ well are seen, in cases where the organism load may be low or multiple samples are tested the IFA may lose its time advantage as the PCR can test up to 11 samples per assay with relatively little addition to the overall time required for one sample. The interpretation of IFAs requires a trained and skilled operator for an accurate diagnosis to be made. In our experience the cyst form may be confused at times with other fungi which occasionally fluoresce despite the use of a specific monoclonal conjugate. In contrast, the nested PCR result is usually easy to read even for the untrained eye. The disadvantage of PCR is the possibility of contamination but if strict protocols are observed, the contamination risk is minimised. There is a perception that PCR is an expensive assay but our estimates indicate it is not necessarily more expensive in terms of labour and accommodation and is less expensive in terms of consumables and capital costs than IFA. The cost of setting up the PCR assay has also to be compared with the improved diagnosis it can provide: earlier diagnosis can mean quicker treatment and shorter hospital stays for patients, especially as many are in expensive intensive care beds; the use of less invasive samples; and the reduced need for repeat sampling for a diagnosis. Therefore, PCR is likely to be of cost benefit to the routine laboratory in the diagnosis of PCP.
These results indicate that for the majority of patients IFA continues to be one of the most sensitive methods for the rapid diagnosis of PCP. In patients with HIV/AIDS no differences were observed between IFA and PCR with both invasive (BAL) and less invasive (induced sputum) samples. In 
